PLSE
PULSE BIOSCIENCES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$53.87
+6.44%Sep 15, 2026, 20:47 UTC
Pulse Biosciences terminated its at-the-market offering program under its prior equity distribution agreement with TD Securities (USA) LLC dated February 19, 2026.
Sep 15, 2026, 20:47 UTC
Pulse Biosciences entered into an equity distribution agreement with Mizuho Securities USA LLC as sales agent for an at-the-market offering of up to $85 million of common stock.
Aug 7, 2026, 00:13 UTC
Pulse Biosciences, Inc reported a second-quarter loss of $0.36 per share, missing the Zacks Consensus Estimate of a $0.31 loss and wider than the year-ago loss of $0.28 per share.